NewsBenzingaNovo Nordisk wird auf AASLDs The Liver Meeting 2026 12 neue Forschungsabstracts zu Semaglutid und MASH vorstellen Novo Nordisk wird auf AASLDs The Liver Meeting 2026 12 neue Forschungsabstracts zu Semaglutid und MASH vorstellen Benzinga 2026.10.28 13:06 (GMT+0) Open on Benzinga Other news Nvidia’s $105 Billion OpenAI Bet Has a 20-Year Catch Freedom Broker Upgrades Espey Manufacturing to Buy, Maintains Price Target to $70 QUICK SPARK: Chip Stocks Eye Worst Two-Month Drop Since 2008 Carlyle, Clearlake Bet Big On Sports — And PE Deals Are Surging Target's $301 Million Tariff Windfall 'Flattered' Earnings, Analyst Says Freedom Broker Maintains Buy on SKYX Platforms, Lowers Price Target to $2